Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 25, 2024, titled "Strides receives USFDA approval for Pregabalin Capsules".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 25, 2024, titled "Strides receives USFDA approval for Pregabalin Capsules".